Drug Research
Drug Discovery & Development

Innovation that leads to transformation: Join us during CPhI and live the Softigel experience!

Published 09 April 2018 | By Softigel pbr

Softigel by Procaps will be attending CPhi North America´s second edition once again, our team of experts will be delighted to sit with you, discuss mutual opportunities and live the Softigel experience.

Softigel

Softigel by Procaps offers customers full-service, turnkey solutions in OTC and prescription products thanks to its softgel development and manufacturing expertise. We are focused on developing complex products encapsulated in softgel dosage forms and other delivery systems, high potency APIs, differentiated OTC products and nutritional supplements in novel technologies.

We offer a wide range of OTC monograph products in different softgel technologies, with flexible options including customized packaging solutions that range from pack development to full commercial scale packaging with modern, state-of-the-art equipment to bring value and flexibility to our customers' supply chains.

We are one of the worlds´ largest softgel encapsulator, and offer our customers deep gelatin and formulation expertise as well as regulatory support through all cycle stages. Our softgel facilities are approved by FDA, MHRA and TGA.

At CPhI North America, Softigel seeks new OTC consumer healthcare, generic Rx and pharma customers with collaboration opportunities inside the US, other highly regulated markets or elsewhere worldwide, interested in the development of single to complex formulations in our advanced softgel dosage forms, clinical manufacturing, commercial manufacturing, tech-transfer, delivering the expertise you need and the innovation you demand.